William Burden
Destin, FLNPI 1417038704
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $29,185 of the $40,189 with a category attached, or 72.6%. AbbVie accounts for 98.2% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $22,928 and has fallen 91.1% since, to $2,045 in 2025.
Across 357 payments — averaging $112.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$39K
- Galderma Laboratories, L.p.$251
- Tepha Inc$159
- Mentor Worldwide LLC$90
- Revance Therapeutics, Inc.$66
- Merz North America, Inc.$47
- plus $94 from 4 others
Across 1 payment — averaging $3500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sientra, Inc.$4K
What the payments were for
- Consulting fees$3001%
- Speaking & faculty fees$29,18573%
- Travel & lodging$1,6434%
- Food & beverage$9,06123%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 335 | $39,481 |
| Galderma Laboratories, L.p. | 8 | $251 |
| Tepha Inc | 1 | $159 |
| Mentor Worldwide LLC | 3 | $90 |
| Revance Therapeutics, Inc. | 2 | $66 |
| Merz North America, Inc. | 1 | $47 |
| Integra Lifesciences Corporation | 2 | $37 |
| TELA Bio, Inc. | 2 | $22 |
| Apyx Medical Corporation | 2 | $21 |
| Sientra, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE$14,331
- ALLODERM$13,675
- STRATTICE$13,675
- NATRELLE SALINE-FILLED BREAST IMPLANTS$1,551
- BOTOX$597
- BOTOX COSMETIC$500
- REVOLVE$437
- GalaFLEX$159
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $270 |
| Scopolamine | 11 | $153 |
| Promethazine Hcl | 19 | $95 |
| Ondansetron Hcl | 17 | $37 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.